These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36573569)

  • 1. Performance of risk prediction models in breast cancer screening among women in Cyprus.
    Danladi C; Serakinci N
    East Mediterr Health J; 2022 Dec; 28(12):888-895. PubMed ID: 36573569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
    Ghoncheh M; Ziaee F; Karami M; Poorolajal J
    Clin Breast Cancer; 2017 Jun; 17(3):e113-e118. PubMed ID: 28216418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
    Quante AS; Whittemore AS; Shriver T; Hopper JL; Strauch K; Terry MB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25956172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
    Zhang L; Jie Z; Xu S; Zhang L; Guo X
    Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing BRCA carrier probabilities in extended families.
    Barcenas CH; Hosain GM; Arun B; Zong J; Zhou X; Chen J; Cortada JM; Mills GB; Tomlinson GE; Miller AR; Strong LC; Amos CI
    J Clin Oncol; 2006 Jan; 24(3):354-60. PubMed ID: 16421416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.
    Fischer C; Kuchenbäcker K; Engel C; Zachariae S; Rhiem K; Meindl A; Rahner N; Dikow N; Plendl H; Debatin I; Grimm T; Gadzicki D; Flöttmann R; Horvath J; Schröck E; Stock F; Schäfer D; Schwaab I; Kartsonaki C; Mavaddat N; Schlegelberger B; Antoniou AC; Schmutzler R;
    J Med Genet; 2013 Jun; 50(6):360-7. PubMed ID: 23564750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Prediction Model Development for Late On-Set Breast Cancer Screening in Low- and Middle-Income Societies: A Model Study for North Cyprus.
    Danladi CD; Serakinci N
    Healthcare (Basel); 2020 Jul; 8(3):. PubMed ID: 32708661
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.
    Ståhlbom AK; Johansson H; Liljegren A; von Wachenfeldt A; Arver B
    Fam Cancer; 2012 Mar; 11(1):33-40. PubMed ID: 22124624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk.
    Allman R; Mu Y; Dite GS; Spaeth E; Hopper JL; Rosner BA
    Breast Cancer Res Treat; 2023 Apr; 198(2):335-347. PubMed ID: 36749458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
    Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
    Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.
    MacInnis RJ; Knight JA; Chung WK; Milne RL; Whittemore AS; Buchsbaum R; Liao Y; Zeinomar N; Dite GS; Southey MC; Goldgar D; Giles GG; Kurian AW; ; Andrulis IL; John EM; Daly MB; Buys SS; Phillips KA; Hopper JL; Terry MB
    J Natl Cancer Inst; 2021 Jun; 113(6):785-791. PubMed ID: 33301022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of breast cancer risk factors in Cyprus: a case control study.
    Hadjisavvas A; Loizidou MA; Middleton N; Michael T; Papachristoforou R; Kakouri E; Daniel M; Papadopoulos P; Malas S; Marcou Y; Kyriacou K
    BMC Cancer; 2010 Aug; 10():447. PubMed ID: 20727220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.
    MacInnis RJ; Bickerstaffe A; Apicella C; Dite GS; Dowty JG; Aujard K; Phillips KA; Weideman P; Lee A; Terry MB; Giles GG; Southey MC; Antoniou AC; Hopper JL
    Br J Cancer; 2013 Sep; 109(5):1296-301. PubMed ID: 23942072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).
    Gao F; Machin D; Chow KY; Sim YF; Duffy SW; Matchar DB; Goh CH; Chia KS
    BMC Cancer; 2012 Nov; 12():529. PubMed ID: 23164155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
    Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
    Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.